Adjuvant compositions for vaccines
OwnerThierry Boon, Silvia Silla +1inventors
InventorsTHIERRY BOON, SILVIA SILLA, CATHERINE UYTTENHOVE
Life of this patent
Estimating the term…
Abstract
The present invention provides improved adjuvant compositions comprising QS21/3DMPL and Interleukin 12. These find utility in a range of prophylatic and therapeutic vaccines, including cancer vaccines. 09/445903
Claims10
A vaccine composition comprising a saponin adjuvant, monophosphoryl lipid A or derivative thereof, Interleukin 12, and an antigen.
A vaccine composition as claimed herein for use in medicine.
Use of a saponin adjuvant, monophosphoryl lipid A or a derivative thereof and Interleukin 12 and an antigen in the manufacture of a vaccine for the treatment of prophylaxis of pathogenic infections or cancer.
A method of enhancing an immune response to an antigen comprising administering the antigen with an adjuvant composition as described in cairns 1 to 4:
A method of treating or preventing a pathogenic infection in a patient comprising administering a vaccine as claimed herein.
Dependencies are inferred from the claim text.